First human test for new IPF inhaler begins
Disease control
Recruiting now
This is the first study in people to test the safety of an experimental inhaled medicine called AGMB-447 for idiopathic pulmonary fibrosis (IPF), a serious lung-scarring disease. The study will enroll healthy volunteers and people with IPF to see how their bodies handle single an…
Phase: PHASE1 • Sponsor: Agomab Spain S.L. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC